GOG 281: Trametinib in recurrent low-grade serous ovarian cancer
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer.
Shitanshu Uppal
MIRASOL: Mirvetuximab in Platinum Resistant Cancer
Mirvetuximab Soravtansine (MIRV) in platinum resistant ovarian cancer
RHIP Framework for Change Management
RHIP framework can help with change management
EORTC-55994 and Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
EORTC and the trial from TATA memorial. Is neoadjuvant chemotherapy and surgery an alternative to chemoradiation in locally advanced cervical cancer?
DUO-E Trial
Does adding durvalumab (a PD-L1 inhibitor) and olaparib (a PARP inhibitor) to standard chemotherapy improve outcomes in advanced or recurrent endometrial cancer?
Open Radical Hysterectomy
Radical Hysterectomy Tutorial
Publications Update # 40
RHIP framework for change, MIRASOL and CALLA summaries
Publications Update # 39
Gratitude as a habit, sentinel lymph node dissection in EIN/CAH, cervical cancer practice guidelines and TPN in patients with an enterocutaneous fistula
Mental Health Crisis in Surgeons
Anxiety, bipolar and addictions
Perfection
How to avoid the perfection trap